Airway Medix S.A.
ISIN: PLAIRWY00017 | Ticker: AWM | LEI: 259400MDMODKWHZ2EU17
Country: Poland
Airway Medix S.A. focuses on research and development work and commercialisation of innovative, disposable devices for the mechanically ventilated patients in the Intensive Care Units (ICU), and for the patients in life-threatening conditions in the anaesthesiology departments.
The family of products developed by Airway Medix is aimed at limiting the growth of a biofilm in patients, reducing the microbial flora in the oral cavity and improving the fitting and tightness of intubation tubes. By reducing biofilm formation and preventing entry of infected material into the lungs, the products protect patients from acquiring Ventilation Associated Pneumonia (VAP).
Ventilation Associated Pneumonia is considered one of the most serious and most costly hospital-acquired infections.
2013
Served areaWorldwide
HeadquartersGen. Zajączka 11/14, 01-510 Warszawa – Poland
| Line item in (pln) | 02.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Assets | N/A | 51,483,000.00 | 44,496,000.00 |
| Noncurrent Assets | N/A | 29,048,000.00 | 38,582,000.00 |
| Property Plant And Equipment | N/A | 2,374,000.00 | 89,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 25,299,000.00 | 37,706,000.00 |
| Deferred Tax Assets | N/A | 1,375,000.00 | 787,000.00 |
| Current Assets | N/A | 22,435,000.00 | 5,914,000.00 |
| Inventories | N/A | 220,000.00 | 332,000.00 |
| Trade And Other Current Receivables | N/A | 780,000.00 | 510,000.00 |
| Current Tax Assets Current | N/A | 0.00 | 0.00 |
| Other Current Financial Assets | N/A | 4,683,000.00 | 5,043,000.00 |
| Cash and cash equivalents | 707,000.00 | 2,215,000.00 | 29,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 22,435,000.00 | 5,914,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | 0.00 |
| Equity And Liabilities | N/A | 51,483,000.00 | 44,496,000.00 |
| Equity | 32,830,000.00 | 30,653,000.00 | 23,901,000.00 |
| Issued Capital | N/A | 19,862,000.00 | 19,862,000.00 |
| Retained Earnings | N/A | 6,026,000.00 | -1,103,000.00 |
| Share Premium | N/A | 1,174,000.00 | 1,174,000.00 |
| Reserve Of Sharebased Payments | N/A | 1,147,000.00 | 1,147,000.00 |
| Capital Reserve | N/A | 1,952,000.00 | 1,952,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 30,653,000.00 | 23,901,000.00 |
| Noncontrolling Interests | N/A | 0.00 | 0.00 |
| Liabilities | N/A | 20,830,000.00 | 20,595,000.00 |
| Noncurrent Liabilities | N/A | 7,865,000.00 | 2,266,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 349,000.00 | 321,000.00 |
| Noncurrent Government Grants | N/A | 1,497,000.00 | 1,457,000.00 |
| Deferred Tax Liabilities | N/A | 3,271,000.00 | 357,000.00 |
| Longterm Borrowings | N/A | 117,000.00 | 131,000.00 |
| Current Liabilities | N/A | 12,965,000.00 | 18,329,000.00 |
| Current Provisions For Employee Benefits | N/A | 367,000.00 | 1,154,000.00 |
| Other Shortterm Provisions | N/A | 54,000.00 | 67,000.00 |
| Trade And Other Current Payables | N/A | 2,100,000.00 | 3,793,000.00 |
| Current Tax Liabilities Current | N/A | 30,000.00 | 87,000.00 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 12,965,000.00 | 18,329,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | 0.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 10,293,000.00 | 13,228,000.00 |
| Line item in (pln) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Revenue | 257,000.00 | 6,000.00 |
| Other Income | 92,000.00 | 20,060,000.00 |
| Raw Materials And Consumables Used | 0.00 | 0.00 |
| Services Expense | 1,907,000.00 | 1,444,000.00 |
| Wages And Salaries | 225,000.00 | 310,000.00 |
| Social Security Contributions | 4,000.00 | 5,000.00 |
| Depreciation And Amortisation Expense | 0.00 | 0.00 |
| Tax Expense Other Than Income Tax Expense | 70,000.00 | 13,000.00 |
| Other Expense By Nature | 0.00 | 0.00 |
| Finance Income | 995,000.00 | 406,000.00 |
| Finance Costs | 767,000.00 | 1,513,000.00 |
| Profit Loss Before Tax | -1,986,000.00 | -9,369,000.00 |
| Income Tax Expense Continuing Operations | 388,000.00 | -2,325,000.00 |
| Profit Loss From Continuing Operations | -2,374,000.00 | -7,044,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 |
| Profit (loss) | -2,374,000.00 | -7,044,000.00 |
| Profit Loss Attributable To Owners Of Parent | -2,374,000.00 | -7,044,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 |
| Line item in (pln) | 01.01.2021 | 02.01.2020 | 01.01.2022 |
|---|---|---|---|
| Profit (loss) | -2,374,000.00 | N/A | -7,044,000.00 |
| Adjustments For Decrease Increase In Inventories | -29,000.00 | N/A | -112,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 19,000.00 | N/A | 14,254,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -332,000.00 | N/A | 639,000.00 |
| Other Adjustments For Noncash Items | 230,000.00 | N/A | -431,000.00 |
| Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | 0.00 | N/A | -27,308,000.00 |
| Other Adjustments To Reconcile Profit Loss | -33,000.00 | N/A | 110,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 65,000.00 | N/A | -45,000.00 |
| Cash Flows From Used In Operating Activities | -2,248,000.00 | N/A | -5,853,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 7,000.00 | N/A | 0.00 |
| Cash Flows From Used In Investing Activities | -5,016,000.00 | N/A | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | 9,858,000.00 | N/A | 3,713,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 917,000.00 | N/A | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 215,000.00 | N/A | 0.00 |
| Cash Flows From Used In Financing Activities | 8,726,000.00 | N/A | 3,713,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 1,462,000.00 | N/A | -2,140,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 46,000.00 | N/A | -46,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 1,508,000.00 | N/A | -2,186,000.00 |
| Cash and cash equivalents | 2,215,000.00 | 707,000.00 | 29,000.00 |
Please note that some sums might not add up.
PLAIRWY00017
LEI259400MDMODKWHZ2EU17
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.